The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n3.3986Keywords:
drug-related side effects and adverse reactions, nausea, vomiting, neoplasms, childAbstract
Introduction: Chemotherapy-induced nausea and vomiting (CINV) are common adverse drug reactions (ADR) experienced by children undergoing treatment for cancer. New paediatric ADR Assessment Causality and Avoidability tools (LCAT and LAAT) of Liverpool are suitable for categorizing factors related to ADR prevention and improving patient care. Still, no studies to date have compared the utility and results of its application for CINV in countries with different levels of development. Objective: To investigate the utility of the Liverpool Adverse Drug Reaction Causality and Avoidability Assessment Tools (LCAT and LAAT) in assessing CINV in children. Method: Prospective observational study of CINV assessment in children aged 4 to 16 years from Alder Hey Children’s Hospital (Liverpool, UK) and “Instituto de Puericultura e Pediatria Martagão Gesteira” (Rio de Janeiro, Brazil). Children (helped by the parents) completed a symptom diary during chemotherapy and for 24 hours after treatment. Information regarding underlying diagnosis, past medical history, and medications administered was collected from the patient record. Case reports were prepared, and the temporal relationship between nausea and vomiting and exposure to chemotherapy, including any strategy to prevent CINV, was recorded. The causality and avoidability were assessed with LCAT and LAAT, respectively. Results: There were 26 reports of CINV in 36 chemotherapy cycles. The causality assessment was ‘definite’ for 24 cases. Twenty ADRs were deemed ‘definitely avoidable’ and four ‘not avoidable’. Selection of inappropriate therapeutic options and non-administration of antiemetic were the most common factors observed in the hospitals studied. Conclusion: The LCAT and LAAT were helpful for assessing CINV in children in two different hospitals.
Downloads
References
Van Laar ES, Desai JM, Jatoi A. Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers. Support Care Cancer. 2015;23(1):151-7. doi: https://doi.org/10.1007/s00520-014-2325-x DOI: https://doi.org/10.1007/s00520-014-2325-x
Phillips RS, Friend AJ, Gibson F, et al. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood. Cochrane Database of Syst Rev. 2016;2(2):CD007786. doi: https://doi.org/10.1002/14651858.CD007786.pub3 DOI: https://doi.org/10.1002/14651858.CD007786.pub3
Patel H, Gurumurthy P. Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety. Int J Clin Pharm. 2019;41(4):981-92. doi: https://doi.org/10.1007/s11096-019-00860-0 DOI: https://doi.org/10.1007/s11096-019-00860-0
Evans A, Vingelen MB, Yu C, et al. Nausea in numbers: electronic medical record nausea and vomiting assessment for children with cancer. J Pediatr Oncol Nurs. 2020;37(3):195-203. doi: https://doi.org/10.1177/1043454219900467 DOI: https://doi.org/10.1177/1043454219900467
Antonarakis ES. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice. Arch Dis Child. 2004;89(9):877-80. doi: https://doi.org/10.1136/adc.2003.037341 DOI: https://doi.org/10.1136/adc.2003.037341
Uppsala Monitoring Centre [Internet]. Sweden: Uppsala Monitoring Centre; [cited 2023 Mar 23]. Available from: https://who-umc.org/
Anderson BJ, Lerman J, Coté CJ. Pharmacokinetics and Pharmacology of drugs used in children. In: Coté CJ, Lerman J, Anderson BJ, editors. A practice of anesthesia for infants and children [Internet]. Philadelphia (PA): Elsevier; 2019 [cited 2023 Mar 23]. p. 100-176.e45. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323429740000070 DOI: https://doi.org/10.1016/B978-0-323-42974-0.00007-0
Gallagher RM, Kirkham JJ, Mason JR, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One. 2011;6(12):e28096. doi: https://doi.org/10.1371/journal.pone.0028096 DOI: https://doi.org/10.1371/journal.pone.0028096
Bracken LE, Nunn AJ, Kirkham JJ, et al. Development of the Liverpool adverse drug reaction avoidability assessment tool. PLoS One. 2017;12(1):e0169393. doi: https://doi.org/10.1371/journal.pone.0169393 DOI: https://doi.org/10.1371/journal.pone.0169393
Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015;8(4):449-60. doi: https://doi.org/10.1586/17512433.2015.1053391 DOI: https://doi.org/10.1586/17512433.2015.1053391
Aapro M, Jordan K, Feyer P. Prevention of nausea and vomiting in cancer patients [Internet]. London: Springer Healthcare; c2013 [cited 2023 Mar 23]. Available from: https://link.springer.com/book/10.1007/978-1-907673-58-0 DOI: https://doi.org/10.1007/978-1-907673-58-0
Paw Cho Sing E, Robinson PD, Flank J, et al. Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline. Pediatr Blood Cancer. 2019;66(5):e27646. doi: https://doi.org/10.1002/pbc.27646 DOI: https://doi.org/10.1002/pbc.27646
Patel P, Robinson PD, Thackray J, et al. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update. Pediatr Blood Cancer. 2017;64(10):e26542. doi: https://doi.org/10.1002/pbc.26542 DOI: https://doi.org/10.1002/pbc.26542
Dupuis LL, Sung L, Molassiotis A, et al. 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children. Support Care Cancer. 2017;25(1):323-31. doi: https://doi.org/10.1007/s00520-016-3384-y DOI: https://doi.org/10.1007/s00520-016-3384-y
Mazlum S, Chaharsoughi NT, Banihashem A, et al. The effect of massage therapy on chemotherapy-induced nausea and vomiting in pediatric cancer. Iran J Nurs Midwifery Res. 2013;18(4):280-4. Cited in: PubMed; PMID: 24403922.
Smyth RL, Peak M, Turner MA, et al. ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods. Programme Grants Appl Res. 2014;2(3):1-184. doi: https://doi.org/10.3310/pgfar02030 DOI: https://doi.org/10.3310/pgfar02030
Thiesen S, Conroy EJ, Bellis JR, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med. 2013;11:237. doi: https://doi.org/10.1186/1741-7015-11-237 DOI: https://doi.org/10.1186/1741-7015-11-237
Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.
Beauchemin M, Sung L, Hershman DL, et al. Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults. Support Care Cancer. 2020;28(10):4761-9. doi: https://doi.org/10.1007/s00520-020-05310-6 DOI: https://doi.org/10.1007/s00520-020-05310-6
Bellare PS, Ashwin K, Prakash PU S, et al. A retrospective evaluation of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in south India. J Young Pharm. 2016;8(3):251-4. doi: https://doi.org/10.5530/jyp.2016.3.14 DOI: https://doi.org/10.5530/jyp.2016.3.14
Children’s Cancer and Leukaemia Group [Internet]. Leicester (UK): CCLG; [date unknown]. Chemotherapy induced nausea and vomiting; [cited 2021 Dec 2]. Available from: https://www.cclg.org.uk/CSOIR/Chemotherapy-induced-nausea-and-vomiting
Fornasier G, Taborelli M, Francescon S, et al. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. Int J Clin Pharm. 2018;40(4):795-802. doi: https://doi.org/10.1007/s11096-018-0653-5 DOI: https://doi.org/10.1007/s11096-018-0653-5
Abunahlah N, Sancar M, Dane F, et al. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life. Int J Clin Pharm. 2016;38(6):1464-76. doi: https://doi.org/10.1007/s11096-016-0393-3 DOI: https://doi.org/10.1007/s11096-016-0393-3
Organisation for Economic Cooperation and Development; World Health Organization, World Bank Group. Delivering quality health services: a global imperative. Geneva: WHO; 2018.
França MS, Usón Junior PLS, Antunes YPPV, et al. Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy. Einstein (São Paulo). 2015;13(2):221-5. doi: https://doi.org/10.1590/S1679-45082015AO3097 DOI: https://doi.org/10.1590/S1679-45082015AO3097
Elshafie S, Zaghloul I, Roberti AM. Pharmacovigilance in developing countries (part I): importance and challenges. Int J Clin Pharm. 2018;40(4):758-63. doi: https://doi.org/10.1007/s11096-017-0570-z DOI: https://doi.org/10.1007/s11096-017-0570-z
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
